The hallmark of the menstrual cycle is extensive steroid-dependent tissue turnover. Estrogen mediates endometrial cell growth and structural remodeling, whereas progeserone suppresses estrogen-dependent proliferation and promotes cellular differentiation. In nonfertile cycles, tissue degradation and menstruation occur as a consequence of steroidal deprivation as the ovarian corpus luteum fails. Stromalepithelial interactions are recognized as a necesary component in mediating steroid-induced endometrial turnover. Specific mRNAs for metalloproteinases of the stromelysin family are expressed during endometrial growth and menstrual breakdown but are absent in the progestin-dominated secretory phase. This expression pattern suggss involvement of stromelysins in remodeling the extracellular matrix of the endometrium during tissue growth and breakdown and implicates progesteronE in the suppression of these enzymes. We examined the regulation of endometrial stromelysins in explant cultures and found no acute effect ofestradiol on their expression, whereas progesterone was a potent inhibitor of stromelysin expression. Progesterone also suppressed stromelysin expression in cultures ofisolated stromal cells, but epithelial cells were progesterone insensitive. Coculture ofrecombined stromal and epithelial cells restored steroidal suppression of the epithelial-specific metalloproteinase. Our data confirm that progesterone inhibits endometrial stromelysins and further demonstrate the necessity for a stromalderived factor(s) as a mediator of steroid suppression of an epithelial metalloproteinase.
epithelial interactions are recognized as a necesary component in mediating steroid-induced endometrial turnover. Specific mRNAs for metalloproteinases of the stromelysin family are expressed during endometrial growth and menstrual breakdown but are absent in the progestin-dominated secretory phase. This expression pattern suggss involvement of stromelysins in remodeling the extracellular matrix of the endometrium during tissue growth and breakdown and implicates progesteronE in the suppression of these enzymes. We examined the regulation of endometrial stromelysins in explant cultures and found no acute effect ofestradiol on their expression, whereas progesterone was a potent inhibitor of stromelysin expression. Progesterone also suppressed stromelysin expression in cultures ofisolated stromal cells, but epithelial cells were progesterone insensitive. Coculture ofrecombined stromal and epithelial cells restored steroidal suppression of the epithelial-specific metalloproteinase. Our data confirm that progesterone inhibits endometrial stromelysins and further demonstrate the necessity for a stromalderived factor(s) as a mediator of steroid suppression of an epithelial metalloproteinase.
The human endometrium undergoes extensive estradiolinduced growth and remodeling during the proliferative phase of the menstrual cycle, followed by secretory maturation in response to postovulatory progesterone (1) . This rapid and extensive degree of steroid-mediated tissue development, which rivals that of many neoplasias, appears to be a necessary component of providing an environment suitable for sustaining hemochorial placentation (2) . In the absence of implantation and the continued progestational environment of pregnancy, the superficial functionalis region of the endometrium undergoes degradation and is expelled with menstrual blood flow. Several laboratories have recently described the expression of matrix metalloproteinases (MMPs) in the normal, cycling human endometrium (3) (4) (5) (6) . These enzymes degrade many components of the extracellular matrix, including proteoglycans, glycoproteins, and basement membrane collagens (7). Our studies (5, 6) identified a cell type-specific expression pattern of mRNAs coding for members of the stromelysin family only during the proliferative and premenstrual/menstrual stage of the cycle; none of the enzymes were identified during the progesterone-dominated secretory menstrual interval. This pattern of expression suggests an active role for stromelysins during growth-associated structural remodeling as well as during the extensive tissue breakdown associated with menstruation.
MMPs of the stromelysin family are also known to be involved in other reproductive-tract functions, including ovulation, implantation, parturition, and postpartum involution of the uterus (8) (9) (10) (11) (12) (13) (14) . The stromelysins also play a role in nonreproductive-tissue processes, such as organ morphogenesis during embryonic development (15) (16) (17) , and in the pathological process of tumor invasion and!metastasis (18) (19) (20) (21) (22) .
The absence of endometrial stromelysins during the secretory interval strongly suggests that progesterone suppresses their expression. Progesterone has been reported to regulate the activity of collagenase and gelatinases in endometrial explants (4) . However, it is not known whether steroids can affect the expression of endometrial stromelysins. Neither is it understood whether the suppression of MMPs during the menstrual cycle reflects a direct response to steroidal signals or the participation of local autocrine or paracrine mechanisms. A principal role for cell-cell interactions has long been recognized in mediating aspects of steroid action during growth and differentiation in numerous adult tissues, including the endometrium (23, 24) . The cellular language by which cell-cell interactions can occur is complex, involving growth factors (25) (26) (27) , cytokines (28) , extracellular matrix components (29) , and direct cell contact (30) .
In this report, we describe in vitro studies which explore the role(s) of estradiol and progesterone in the regulation of stromelysins in the human endometrium. Explants of intact endometrium, as well as isolated and recombined cell types, were cultured in the presence or absence of these steroids. While estradiol had no acute effect on endometrial stromelysin expression, progesterone suppressed the secretion of both an epithelial-and a stromal-specific stromelysin in explants of endometrium. Isolated endometrial stromal cells were also progesterone sensitive in culture, but isolated epithelial cells continued to secrete an epithelial-specific MMP in the presence of progesterone. Coculture of recombined epithelial and stromal cells separated by an adjacent permeable membrane or in a physically separated culture environment restored progesterone suppression of the epithelial-specific stromelysin. hr in DMEM/F12 with 5% charcoal-stripped, heatinactivated calf serum before initiation of serum-free conditions. In coculture experiments, stromal cells were allowed to attach for 3-4 hr to the bottom of collagen-coated inverted tissue culture inserts or to a collagen coating on the bottom of the culture well before epithelial cells were transferred to the wells in the interior of culture inserts. After cell attachment, each culture was maintained in serum-free DMEM/ F12 supplemented with 1% ITS+ and 0.1% Excyte. As with explant cultures, treatments ofisolated cells included control (no hormones), estradiol (10 nM), and progesterone (500 nM).
MATERIALS AND METHODS
For standardization, initiation of serum-free conditions was considered day 0 of culture. Media were changed at 2-to 3-day intervals except during the last 18 (35) .
RESULTS
The in vivo expression pattern of endometrial stromelysins from our previous work (5, 6) is graphically summarized in Fig. 1 (20, 32) was detected in explants of proliferative-phase endometrium cultured under control conditions or in the presence of estradiol ( Fig. 2A) . Treatment of explants from the proliferative phase with progesterone markedly inhibited promatrilysin secretion. Explant cultures of tissue acquired during the secretory phase produced negligible promatrilysin in vitro, which is consistent with the lack of matrilysin mRNA expression observed during this phase of the cycle (5) . The expression of a stromal-specific MMP, stromelysin, was similar to that of the epithelial-specific matrilysin in explant cultures of endometrium, again reflecting the in vivo expression pattern for stromal-specific MMPs (6) . Immunoprecipitation with the anti-stromelysin antibody revealed a 59-to 60-kDa protein corresponding to prostromelysin (21, 33) in control or estradiol-treated explants of proliferative-phase, but not secretory-phase, endometrium (Fig. 2B) . Progesterone treatment markedly reduced the level of prostromelysin produced in endometrial explants established from tissue obtained during the proliferative phase. Over the time course of these endometrial explant cultures (48 hr), no clear changes in the amount of either prostromelysin or promatrilysin were observed following treatment with exogenous estradiol, relative to untreated tissues.
To determine whether the suppression of prostromelysin secretion by endometrial explants in vitro reflected a direct progesterone effect on each principal cell type, we examined the regulation ofthese enzymes in cultures ofisolated stromal and epithelial cells. Stromal cells were isolated from proliferative-phase biopsy specimens, cultured in plates for 6 days, and analyzed for steroid-sensitive prostromelysin secretion. A suppression of the 60-kDa prostromelysin protein was observed following progesterone treatment, relative to control or estradiol-treated stromal cells (Fig. 3A) . Progesterone treatment also suppressed the levels of mRNA for both stromelysin 1 and stromelysin 3, whereas estradiol treatment did not significantly affect the message level for either stromelysin examined (Fig. 3B) .
The regulation of matrilysin, which is specifically expressed only in the glandular epithelium ofthe endometrium, was similarly analyzed. Epithelial cells were isolated from proliferative-phase biopsy specimens and established as primary cultures on biomatrix-coated tissue culture inserts. Following attachment to this biomatrix in serum-containing medium, we have previously demonstrated endometrial epithelial cells to maintain an in vivo-like morphology over 6-9 days under serum-free conditions (36) . Cultures of isolated epithelial cells secreted the 30-kDa promatrilysin for 5-9 days (Fig. 4) . As opposed to the results obtained with explant cultures of intact endometrium and monolayer cultures of isolated stromal cells, the secretion of promatrilysin by isolated epithelium in vitro was not steroid sensitive (Fig. 4) . Neither progesterone nor estradiol affected promatrilysin protein secretion by cultures of isolated endometrial epithelium as compared with control cultures.
Since progesterone readily suppressed prostromelysin secretion by stromal cells but failed to suppress matrilysin secretion by isolated epithelial cells in vitro, we examined the possibility that stromal cells may secrete a paracrine factor, in response to progesterone, that affects epithelial promatrilysin secretion. Cocultures of isolated and recombined stro- In B, the same blot was stripped and hybridized to a probe for cyclophilin (Cyc) mRNA, which is constitutively expressed.
Se(C rT t ()T-\ Under these conditions, a limited degree of direct cell-cell contact could occur through the membrane pores. Progesterone suppressed secretion of radiolabeled promatrilysin in a representative coculture experiment (Fig. 4) . Similar coculture experiments were subsequently conducted with stromal cells attached to the bottom of culture wells (where no direct cell-cell contact across the permeable membrane would be possible). Suppression of promatrilysin was also observed in these cultures (Fig. 5 ), indicating that a soluble factor(s) is the active stromal signal that can suppress promatrilysin expression by isolated epithelial cells.
DISCUSSION
The endocrine-directed cyclic growth, differentiation, and breakdown of the human endometrium represents perhaps the most dynamic example of steroid-driven tissue turnover in the adult. Recent reports from our laboratory and others (3) (4) (5) (6) (25) (26) (27) (28) (29) (30) . While a principal role for the stroma has been often proposed in mediating steroid action during growth and differentiation in numerous adult tissues (23) , including the endometrium (24), our study demonstrates that stromal cells can mediate progesterone suppression of an epithelial-specific protein. Additionally, our results indicate that a soluble factor(s) produced by the stroma in response to progesterone may be the principal signal that suppresses epithelial cell production of promatrilysin. The nature of this soluble factor is, at present, only speculative; however, numerous cytokines and growth factors that are known to regulate the expression of MMPs are prevalent in the human endometrium (28, 38) .
It is unlikely that the requirement for the participation of the stroma in mediating epithelial MMP expression is a relationship unique to the normal cycling endometrium. MMPs are involved in extracellular matrix turnover during many reproductive processes (8) (9) (10) (11) (12) (13) (14) , as well as during normal nonreproductive functions (15) (16) (17) . These potent enzymes also play an important role in the pathological process of tumor invasion and metastasis (18) (19) (20) (21) (22) 
